TubeRank
LCIDBearhit
Lucid CityLucid City

Target Price(split-adjusted)

$24.60

Said $2.46· today's shares after the 1-for-10 reverse split (Sep 2025)

that might be shorts bigger plan to really break lucid on a technical standpoint... just watch for that 246@ 6:23 · open at this moment on YouTube ↗

Thesis at the time

Bearish

Shorts are abnormally increasing position (+2.48M shares) going into a long weekend, a clear sign they are pursuing a specific technical objective — breaking Lucid below the 100-day MA. The speaker notes 57% of options activity is bearish, with large 250 puts purchased for June 20, and flags that a 30% historical drawdown occurs whenever Lucid breaks below its 50-day MA. Management execution delays on promised marketing campaigns and ambassadors are also giving shorts cover.

Key arguments

  • Shorts increased 2.48M shares on pre-holiday Friday — abnormal and strategic
  • 57% of options activity is bearish; large 250 puts bought for June 20 (~28 days out)
  • Lucid broke below the 100-day MA today; 50-day at $2.46 is now next key support
  • Historical pattern: breaking below 50-day MA causes ~30% decline
  • Lucid has delayed on promised marketing campaigns, gravity test drives, and ambassador announcement

Counter-arguments acknowledged

  • All secondary market transactions so far are buys
  • Bulls still expect $3 range by next week

The call

Date said
May 23, 2025
Price at prediction
$25.60
Confidence
medium
Specificity
specific

How it resolved

Status
hit
Resolution price
$24.10
Return
+5.9%
Notes
Target ≤$24.6 reached on 2025-05-29. Price: $24.10. Return: +5.9%.
Why this resolved this way(resolution audit)
Reference price
$25.60 (anchored at quote date)
Target used
$24.60(split-adjusted from $2.46)
Deadline source
Horizon (short → +90d from publish)
Effective: Aug 21, 2025
Age at resolution
0.2 months(from publish date)
Resolution snapshot
$24.10 on May 29, 2025

Rule that fired

Target ≤$24.6 reached on 2025-05-29. Price: $24.10. Return: +5.9%.

Full rules: docs/resolution-spec.md.